Edgar Lomax CO Merck & Co., Inc. Transaction History

Edgar Lomax CO

$1.63 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$100.18 - $109.02 $1.14 Million - $1.24 Million	-11,375 Reduced 3.94%	277,069 $30.2 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $541,002 - $600,804	-5,255 Reduced 1.79%	288,444 $29.7 Million
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $447,581 - $487,843	-4,121 Reduced 1.38%	293,699 $33.9 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $59.8 Million - $66.7 Million	-580,555 Reduced 66.09%	297,820 $31.7 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $445,069 - $570,639	-5,090 Reduced 0.58%	878,375 $97.4 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $562,124 - $631,484	-6,650 Reduced 0.75%	883,465 $76.1 Million
Q2 2022 Aug 10, 2022	BUY	$83.49 - $94.64 $1.86 Million - $2.11 Million	22,305 Added 2.57%	890,115 $81.2 Million
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $22.7 Million - $25.5 Million	309,360 Added 55.4%	867,810 $71.2 Million
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $393,564 - $492,990	-5,445 Reduced 0.97%	558,450 $42.8 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $403,916 - $444,207	-5,635 Reduced 0.99%	563,895 $42.4 Million
Q2 2021 Aug 09, 2021	SELL	$70.31 - $77.77 $1.05 Million - $1.16 Million	-14,950 Reduced 2.56%	569,530 $44.3 Million
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $40.2 Million - $47.4 Million	584,480 New	584,480 $45.1 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $36.5 Million - $41.6 Million	-524,088 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $512,133 - $594,323	-7,850 Reduced 1.48%	524,088 $40 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $1.11 Million - $1.3 Million	-19,170 Reduced 3.48%	531,938 $37.7 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $195,695 - $229,922	3,850 Added 0.7%	551,108 $33.5 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $20.9 Million - $24.3 Million	409,550 Added 297.4%	547,258 $29.8 Million
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $212,416 - $253,648	-4,115 Reduced 2.9%	137,708 $7.75 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $8.32 Million - $8.95 Million	141,823	141,823 $9.08 Million

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$25.8 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$21.4 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$12.3 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.82 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$6.1 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgar Lomax CO, based on Form 13F filings with the SEC.

News

Stay updated on Edgar Lomax CO with notifications on news.

Account